FibroGen FGEN is set to give its latest quarterly earnings report on Monday, 2022-08-08. Here’s what investors need to know before the announcement.
Analysts estimate that FibroGen will report an earnings per share (EPS) of $-0.94.
FibroGen bulls will hope to hear the company to announce they’ve not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
Past Earnings Performance
Last quarter the company beat EPS by $0.15, which was followed by a 25.82% increase in the share price the next day.
Here’s a look at FibroGen’s past performance and the resulting price change:
| Quarter | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 |
|---|---|---|---|---|
| EPS Estimate | -0.83 | -0.45 | ||
| EPS Actual | -0.68 | -1.45 | 0.54 | -1.45 |
| Price Change % | 25.82% | -3.2% | 0.66% | -4.35% |
| Quarter | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 |
|---|---|---|---|---|
| EPS Estimate | -0.83 | -0.45 | ||
| EPS Actual | -0.68 | -1.45 | 0.54 | -1.45 |
| Price Change % | 25.82% | -3.2% | 0.66% | -4.35% |
Stock Performance
Shares of FibroGen were trading at $13.95 as of August 04. Over the last 52-week period, shares are up 2.32%. Given that these returns are generally positive, long-term shareholders should be satisfied going into this earnings release.
To track all earnings releases for FibroGen visit their earnings calendar on our site.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
Image and article originally from www.benzinga.com. Read the original article here.